Astaxanthin Slows Down Skeletal Muscle Atrophy in H22 Tumor-Bearing Mice During Sorafenib Treatment by Modulating the Gut Microbiota.

Astaxanthin supplementation altered the amino acid metabolism in tumor-bearing mice by modulating intestinal flora, thereby reducing the rate of skeletal muscle atrophy in tumor-bearing mice undergoing treatment.